Literature DB >> 12558762

Headache and hemodialysis: a prospective study.

Ana L Antoniazzi1, Marcelo E Bigal, Carlos A Bordini, Stewart J Tepper, José G Speciali.   

Abstract

OBJECTIVE: To determine the prevalence and clinical characteristics of headache in patients undergoing hemodialysis and to compare the prevalence of headache prior to and following the beginning of a hemodialysis program.
BACKGROUND: About 70% of patients receiving hemodialysis complain of headache. Despite this, headaches have not been well studied in this group of patients.
METHODS: We evaluated a series of patients with chronic renal failure who attended 3 hemodialysis services in a Brazilian town from January of 1998 to December of 1999. Patients with headache were prospectively followed and classified according to the International Headache Society criteria. The headaches were also categorized according to their temporal profile relative to hemodialysis.
RESULTS: Headache was reported by 87 (70.7%) of the 123 patients studied. Prior to beginning dialysis, 48% had migraine, 19% had episodic tension-type headache, and 8% had both. Headache related to arterial hypertension was the second most frequent headache diagnosis in these patients (25.4%). Fifty patients (57.5%) experienced headache during the session of hemodialysis. Thirty-four were classified as dialysis headache, 7 were classified as migraine, 7 as episodic tension-type headache, and 2 were unclassified. Twenty-four patients (27.6%) reported dramatic improvement of their headaches after the beginning of the dialysis program.
CONCLUSIONS: Headache is common in patients undergoing hemodialysis. Classification of such headaches according to the International Headache society criteria may be difficult.

Entities:  

Mesh:

Year:  2003        PMID: 12558762     DOI: 10.1046/j.1526-4610.2003.03025.x

Source DB:  PubMed          Journal:  Headache        ISSN: 0017-8748            Impact factor:   5.887


  12 in total

1.  Headache during haemodialysis in a patient with shunt: a cause for concern?

Authors:  Padraig O'Sullivan; Jahangir Sajjad; Sahibzada Abrar; Charles Marks
Journal:  BMJ Case Rep       Date:  2015-03-27

Review 2.  When Headache Warns of Homeostatic Threat: the Metabolic Headaches.

Authors:  Parneet Grewal; Jonathan H Smith
Journal:  Curr Neurol Neurosci Rep       Date:  2017-01       Impact factor: 5.081

Review 3.  Unusual headaches in the elderly.

Authors:  Cynthia C Bamford; MaryAnn Mays; Stewart J Tepper
Journal:  Curr Pain Headache Rep       Date:  2011-08

Review 4.  The metabolic headaches.

Authors:  Marcelo E Bigal; Jonathan Gladstone
Journal:  Curr Pain Headache Rep       Date:  2008-08

5.  Calcium, parathyroid hormone, and vitamin D: major determinants of chronic pain in hemodialysis patients.

Authors:  Eliezer Golan; Isabelle Haggiag; Pnina Os; Jacques Bernheim
Journal:  Clin J Am Soc Nephrol       Date:  2009-07-02       Impact factor: 8.237

Review 6.  Dialysis headache.

Authors:  Ana Luisa de Lima Antoniazzi; Alexandre Pinto Corrado
Journal:  Curr Pain Headache Rep       Date:  2007-08

7.  Migraine and subsequent chronic kidney disease risk: a nationwide population-based cohort study.

Authors:  Shuo-Chun Weng; Chia-Lin Wu; Chew-Teng Kor; Ping-Fang Chiu; Ming-Ju Wu; Chia-Chu Chang; Der-Cherng Tarng
Journal:  BMJ Open       Date:  2017-12-27       Impact factor: 2.692

8.  Headache changes after kidney transplant.

Authors:  Giovanna Viticchi; Lorenzo Falsetti; Sergio Salvemini; Marco Bartolini; Andrea Ranghino; Laura Buratti; Mauro Silvestrini
Journal:  Acta Neurol Belg       Date:  2021-03-09       Impact factor: 2.396

9.  Caffeine-withdrawal headache induced by hemodialysis.

Authors:  Petar M Nikić; Jasna Zidverc-Trajković; Branislav Andrić; Marija Milinković; Biljana Stojimirović
Journal:  J Headache Pain       Date:  2009-04-15       Impact factor: 7.277

Review 10.  Prevalence and severity of pain in adult end-stage renal disease patients on chronic intermittent hemodialysis: a systematic review.

Authors:  Tonci Brkovic; Eliana Burilovic; Livia Puljak
Journal:  Patient Prefer Adherence       Date:  2016-06-23       Impact factor: 2.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.